Paul Blaney

Paul Blaney is a seasoned professional in clinical research and project management, currently serving as the Site Head and Director of Business Enablement at Catalyst Clinical Research since February 2018. At Catalyst, Paul is responsible for the identification, implementation, integration, and ongoing development of clinical systems. Prior roles include leadership positions at AstraZeneca, such as Associate Director of Clinical Development and Strategic Enablement Leader in Clinical Operations, where Paul was instrumental in driving process improvement initiatives and overseeing significant clinical trials. Additionally, Paul has extensive experience as a Global Study Manager at Roche Pharmaceuticals, managing phase II and III studies in oncology and infection. Paul holds a Bachelor of Science degree in Chemistry from The University of Sheffield.